New antiarrhythmic drugs for atrial flutter and atrial fibrillation: A conceptual breakthrough at last?

Circulation

Volumn 105, Issue 3, 2002, Pages 276-278

  Cosío, Francisco G ^a   Delpón, Eva ^a  

^a HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

Author keywords

Antiarrhythmia agents; Atrial fibrillation; Atrial flutter; Editorials

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; FLECAINIDE; PROPAFENONE; SODIUM CHANNEL BLOCKING AGENT;

CALCIUM CONDUCTANCE; CARDIOVASCULAR EFFECT; DRUG EFFICACY; EDITORIAL; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART MUSCLE POTENTIAL; HEART VENTRICLE FIBRILLATION; HUMAN; PRIORITY JOURNAL; REENTRY ARRHYTHMIA; REFRACTORY PERIOD; SINUS RHYTHM; SPECTRAL SENSITIVITY;

EID: 0037154325     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/circ.105.3.276     Document Type: Editorial

References (20)

1. Classification of antiarrhythmic actions
2. Length of excitation wave and susceptibility to reentrant atrial arrhythmias in normal conscious dogs
3. Amiodarone-induced block of sodium current in isolated cardiac cells
4. The Sicilian Gambit: A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms
5. Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm
6. Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainide
7. Atrial flutter can be terminated by a class III antiarrhythmic drug, but not by a class IC drug
8. Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation
9. Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: The symptomatic atrial fibrillation investigative research on Dofetilide (SAFIRE-D) Study
10. Atrial flutter mapping and ablation: I, atrial flutter mapping
11. Characterization of low right atrial isthmus as the slow conduction zone and pharmacological target in typical atrial flutter
12. A new perspective on the mechanisms of arrhythmias and sudden cardiac death: Spiral waves of excitation in heart muscle
13. Vortex shedding as a precursor of turbulent electrical activity in cardiac muscle
14. Preferential depression of conduction around a pivot point in rabbit ventricular myocardium by potassium and flecainide
15. Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat: Effects of cibenzoline, hydroquinine, flecainide, and d-sotalol
16. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care
17. Value of clinical history to assess prognosis of patients with VT or VF after myocardial infarction
18. Comparison of the usefulness of the implantable cardioverter-defibrillator and subendocardial resection in patients with sustained ventricular arrhythmias and poor regional wall motion associated with coronary artery disease
19. Prognosis following sustained ventricular tachycardia occurring early after myocardial infarction